2025-06587NoticeWallet

Could Your Pills Be a National Security Risk? Feds Investigate Imports

Published Date: 4/16/2025

Notice

Summary

The U.S. Department of Commerce is checking if importing medicines and their ingredients could affect national security. They want everyone—businesses, experts, and regular folks—to share their thoughts by May 7, 2025. This could lead to new rules that might change how these important products come into the country, possibly impacting prices and availability.

Analyzed Economic Effects

2 provisions identified: 0 benefits, 1 costs, 1 mixed.

Review of foreign export restrictions on medicines

The investigation will examine the potential for export restrictions by foreign nations, including the ability of foreign governments to 'weaponize' control over pharmaceutical supplies. The Department is seeking information on that risk as part of the Section 232 review. Public comments on this topic must be received by May 7, 2025.

Possible tariffs or quotas on drug imports

If you import or manufacture pharmaceuticals or active pharmaceutical ingredients, the Commerce Department has opened a Section 232 investigation to assess national security risks. The investigation explicitly asks whether additional measures, including tariffs or quotas, are necessary to protect national security. The Department is accepting public comments through May 7, 2025.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
4/16/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Industry and Security Bureau
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register